O. Okafor

Cardiac operations and interventions during the COVID-19 pandemic: a nationwide perspective

P. Ludman, F. Leyva, B. Stegemann, 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Endogenous Fibrinolysis: An Important Mediator of Thrombus Formation and Cardiovascular Risk.

D. Gorog, Diana A Gorog, O. Okafor, 2015, Journal of the American College of Cardiology.

Allopurinol as a therapeutic option in cardiovascular disease

K. Farrington, D. Gorog, Diana A Gorog, 2017, Pharmacology & therapeutics.

Acute Hemodynamic Effects of Simultaneous and Sequential Multi-Point Pacing in Heart Failure Patients With an Expected Higher Rate of Sub-response to Cardiac Resynchronization Therapy: Results of Multicenter SYNSEQ Study

A. Sokal, R. Cornelussen, F. Leyva, 2022, Frontiers in Cardiovascular Medicine.

Survival after cardiac resynchronization therapy: results from 50 084 implantations

Asif Ahmed, F. Leyva, J. de Bono, 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Myocardial Fibrosis Predicts Ventricular Arrhythmias and Sudden Death After Cardiac Electronic Device Implantation.

R. Steeds, S. Prasad, F. Leyva, 2022, Journal of the American College of Cardiology.

54 Improvement in Endogenous Thrombolytic Status following Successful Ablation of Atrial Fibrillation

P. Collins, N. Spinthakis, V. Markides, 2015, Heart.

59 Does CHA²DS²VASc Score Correlate with Point-of-Care Global Thrombotic Status in Atrial Fibrillation Patients?

N. Spinthakis, Diana A Gorog, O. Okafor, 2015, Heart.

Right ventricular function and long‐term clinical outcomes after cardiac resynchronization therapy: A cardiovascular magnetic resonance study

F. Leyva, B. Stegemann, W. Moody, 2022, Pacing and clinical electrophysiology : PACE.

Relative effects of different non-vitamin K antagonist oral anticoagulants on global thrombotic status in atrial fibrillation

D. Wellsted, M. Farag, K. Sullivan, 2016, Platelets.

Myocardial Fibrosis as a Predictor of Sudden Death in Patients With Coronary Artery Disease.

R. Steeds, L. Hudsmith, F. Leyva, 2021, Journal of the American College of Cardiology.

Prognosis of incidental left bundle branch block.

R. Steeds, L. Hudsmith, F. Leyva, 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Greyzone myocardial fibrosis and ventricular arrhythmias in patients with a left ventricular ejection fraction >35%

R. Steeds, L. Hudsmith, F. Leyva, 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Arrhythmic Risk Stratification by Cardiovascular Magnetic Resonance Imaging in Patients With Nonischemic Cardiomyopathy

D. Pennell, U. Tayal, A. Gulati, 2024, Journal of the American College of Cardiology.

Changes in QRS Area and QRS Duration After Cardiac Resynchronization Therapy Predict Cardiac Mortality, Heart Failure Hospitalizations, and Ventricular Arrhythmias

P. V. van Dam, F. Leyva, B. Stegemann, 2019, Journal of the American Heart Association.